Answer from: Radiation Oncologist at Community Practice
Happy New Year to the MedNet! This is a great question that should remind us to question everything.
This is an important question that the prostate community I have felt since I was in training has over simplified for decades.
First: Our current nomenclature has problems. Most residents and...
Comments
Radiation Oncologist at UC San Diego Great summary of the data—thank you.
Radiation Oncologist at Millennium Oncology Could not agree more with this. Pleasant to see su...
Radiation Oncologist at Sidney Kimmel Medical College of Thomas Jefferson University Well explained. Separating Onco-lore from data.
Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System Great summary. Yet, you left one piece of gristle ...
Radiation Oncologist at Penn Medicine I do believe that RTOG 0534 started ADT 2 months b...
Answer from: Radiation Oncologist at Academic Institution
Yes, this was an interesting study by Malone et al., which I enjoyed reading. Given the lack of significant advantage to either approach on the study, we continue to typically give 2 months of neoadjuvant ADT.
As opposed to the 3DCRT approach on the study, we use VMAT with fairly tight margin...
Comments
Radiation Oncologist at Mount Sinai Medical Center Miami I thought survival curves in short term Adt studie...
Radiation Oncologist at UC San Diego I do believe ADT has an effect on occult metastase...
Great summary of the data—thank you.
Could not agree more with this. Pleasant to see su...
Well explained. Separating Onco-lore from data.
Great summary. Yet, you left one piece of gristle ...
I do believe that RTOG 0534 started ADT 2 months b...